My Cart [ 0 ]
Home > Antibodies > A-Z Primary Antibodies > Palivizumab Biosimilar, RSV Monoclonal Antibody

Palivizumab Biosimilar, RSV Monoclonal Antibody

Synagis Biosimilar, Anti-RSV Humanized Monoclonal Antibody

Catalog No. Product Name Size List Price (US$) Quantity
C021P Palivizumab Biosimilar, RSV Monoclonal Antibody 10 mg 800.00
C021P Palivizumab Biosimilar, RSV Monoclonal Antibody 50 mg 1200.00
C021P Palivizumab Biosimilar, RSV Monoclonal Antibody 100 mg 2000.00
C021P Palivizumab Biosimilar, RSV Monoclonal Antibody 1 g 6000.00
Description

Palivizumab (trade name Synagis, MedImmune), a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody,  targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.

C021P: Palivizumab Biosimilar, RSV Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Isotype: Human IgG1 kappa.
Source: The monoclonal antibody palivizumab biosimilar was produced in the Synagis biosimilar CHO stable cell line.
Specificity/Sensitivity: The monoclonal antibody palivizumab biosimilar specifically binds to an epitope in the A antigenic site of the F protein of RSV (respiratory syncytial virus).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by palivizumab.
Form of Antibody: 0.2 uM filtered solution, pH 5.2, no stabilizers or preservatives.
Endotoxin: < 0.1 EU per 1 ug of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The monoclonal antibody palivizumab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Related Links

See our Privacy Policy